FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

ALSO NOTED: $50M IT contract at FDA; Court asked to expedite stem cell challenge; and much more...

> The FDA has issued a $50 million contract to High Performance Technologies for IT services. Report

> Lawyers for California's stem-cell research institute have asked an appeals court for an expedited review of a lower court's decision to dismiss challenges to a state bond issue to fund new research. Report

> Bears Stearns analyst John Boris says he expects the FDA to approve Endo Pharmaceuticals' Oxymorphone pain killer. Report

> Hollis-Eden Pharmaceuticals has presented data on five drug candidates for cystic fibrosis. Report

And Finally… Avian flu has claimed another victim in Indonesia, bring the country's death toll to 38 and raising concerns that the country has not effectively countered the crisis. Article


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about drug candidates   Avian Flu   Endo Pharmaceuticals   cystic fibrosis   Stem cells   FDA